Your medical provider will assess your symptoms, X-rays, blood tests, and other laboratory tests to define your OA stage and subsequent treatment plan. This article explains more about the four stages ...
Contineum (CTNM) announced authorization of its investigational new drug, or IND, application from FDA for PIPE-791 for the treatment of chronic pain associated with two separate indications, ...
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
Osteoarthritis is considered a risk factor for severe cardiovascular disease like ischemic heart disease and myocardial infarction. Studying ~60 000 twins over a 20-year period and applying ...
Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...